DNA Synthesis Market By Product and Service (Product, Services), By Type (Oligonucleotide Synthesis, Gene Synthesis), By Application (Diagnostics, Therapeutics, Research and Development), By End User (Pharmaceutical and Biotechnology Companies, Diagnostic Companies, Academic and Research Institutes, Others): Global Opportunity Analysis and Industry Forecast, 2026-2035
The DNA synthesis market was valued at $5.7 billion in 2025 and is estimated to reach $30.4 billion by 2035, exhibiting a CAGR of 18.2% from 2026 to 2035. DNA synthesis refers to the artificial creation of DNA molecules through chemical or enzymatic methods, enabling researchers to design, assemble, and produce customized DNA sequences for a wide range of applications. It plays a critical role in modern biotechnology, molecular biology, synthetic biology, drug discovery, and genetic engineering. DNA synthesis technologies include oligonucleotide synthesis and gene synthesis, which allow the production of short DNA fragments as well as full-length genes with high precision and scalability. These synthesized DNA sequences are widely used in research, diagnostics, therapeutics development, vaccine design, and agricultural biotechnology, making them a foundational tool in life sciences innovation.
The DNA synthesis market has witnessed strong growth, primarily driven by the rise in demand for advanced genomic research and surge in applications in personalized medicine and precision therapeutics. Increase in investments in biotechnology and pharmaceutical R&D have significantly boosted the adoption of synthetic DNA for drug discovery, target validation, and biomarker identification. In addition, the rapid growth of synthetic biology and genetic engineering applications, such as CRISPR-based gene editing, has further accelerated market expansion. The surge in prevalence of chronic and infectious diseases has also intensified the need for rapid diagnostic development and vaccine research, thereby increasing reliance on DNA synthesis technologies across healthcare and research institutions.
However, the market faces certain restraints, including the high cost associated with high-fidelity DNA synthesis and sequencing error correction, which limits accessibility for smaller research laboratories and startups. In addition, technical limitations in synthesizing longer and highly complex DNA sequences with absolute accuracy continue to pose challenges. Regulatory concerns related to biosecurity and the ethical implications of synthetic gene creation also restrict unrestricted market expansion in several regions.
Despite these challenges, the advancements in enzymatic DNA synthesis technologies, which offer higher speed, scalability, and reduced error rates compared to traditional chemical methods, offer significant opportunities for market expansion. The surge in demand for synthetic biology-based solutions in industrial biotechnology, agriculture, and healthcare is expected to further expand application areas. Emerging economies in Asia-Pacific, particularly India and China, are becoming key growth hubs due to increase in investments in genomics infrastructure, surge in number of biotech startups, and supportive government initiatives promoting life sciences research.
The DNA synthesis market is segmented into product & services, type, application, end user, and region. On the basis of product & services, it is bifurcated into product and services. The product segment is further divided into instruments and reagent & consumables. On the basis of type, the market is segregated into oligonucleotide synthesis and gene synthesis. On the basis of application, the market is categorized into diagnostics, therapeutics, and research & development. On the basis of end user, the market is fragmented into pharmaceutical & biotechnology companies, diagnostic companies, academic & research institutes, and others. Region-wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report are Danaher Corporation, Eurofins Scientific SE, Thermo Fisher Scientific Inc., Twist Bioscience, GenScript Biotech Corporation, Merck KGaA, Bioneer Corporation, Telesis Bio, Azenta Inc., and Ajinomoto Bio-Pharma.
Key Benefits For Stakeholders
North America
The DNA synthesis market has witnessed strong growth, primarily driven by the rise in demand for advanced genomic research and surge in applications in personalized medicine and precision therapeutics. Increase in investments in biotechnology and pharmaceutical R&D have significantly boosted the adoption of synthetic DNA for drug discovery, target validation, and biomarker identification. In addition, the rapid growth of synthetic biology and genetic engineering applications, such as CRISPR-based gene editing, has further accelerated market expansion. The surge in prevalence of chronic and infectious diseases has also intensified the need for rapid diagnostic development and vaccine research, thereby increasing reliance on DNA synthesis technologies across healthcare and research institutions.
However, the market faces certain restraints, including the high cost associated with high-fidelity DNA synthesis and sequencing error correction, which limits accessibility for smaller research laboratories and startups. In addition, technical limitations in synthesizing longer and highly complex DNA sequences with absolute accuracy continue to pose challenges. Regulatory concerns related to biosecurity and the ethical implications of synthetic gene creation also restrict unrestricted market expansion in several regions.
Despite these challenges, the advancements in enzymatic DNA synthesis technologies, which offer higher speed, scalability, and reduced error rates compared to traditional chemical methods, offer significant opportunities for market expansion. The surge in demand for synthetic biology-based solutions in industrial biotechnology, agriculture, and healthcare is expected to further expand application areas. Emerging economies in Asia-Pacific, particularly India and China, are becoming key growth hubs due to increase in investments in genomics infrastructure, surge in number of biotech startups, and supportive government initiatives promoting life sciences research.
The DNA synthesis market is segmented into product & services, type, application, end user, and region. On the basis of product & services, it is bifurcated into product and services. The product segment is further divided into instruments and reagent & consumables. On the basis of type, the market is segregated into oligonucleotide synthesis and gene synthesis. On the basis of application, the market is categorized into diagnostics, therapeutics, and research & development. On the basis of end user, the market is fragmented into pharmaceutical & biotechnology companies, diagnostic companies, academic & research institutes, and others. Region-wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report are Danaher Corporation, Eurofins Scientific SE, Thermo Fisher Scientific Inc., Twist Bioscience, GenScript Biotech Corporation, Merck KGaA, Bioneer Corporation, Telesis Bio, Azenta Inc., and Ajinomoto Bio-Pharma.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the dna synthesis market analysis from 2025 to 2035 to identify the prevailing dna synthesis market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the dna synthesis market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global dna synthesis market trends, key players, market segments, application areas, and market growth strategies.
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
- Additional company profiles with specific to client's interest
- Expanded list for Company Profiles
- Historic market data
- Gene Synthesis
- Therapeutics
- Research and Development
- Instruments
- Reagents and Consumables
- Services
- Diagnostic Companies
- Academic and Research Institutes
- Others
North America
- U.S.
- Canada
- Mexico
- Europe Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Eurofins Scientific SE
- Twist Bioscience
- GenScript Biotech Corporation
- Bioneer Corporation
- Telesis Bio
- Ajinomoto Bio-Pharma
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Azenta Inc.
- Danaher Corporation
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. High intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rising Demand for Genomics and Precision Medicine
3.4.1.2. Growth in Synthetic Biology and Biopharmaceutical Innovation
3.4.1.3. Technological Advancements in Automation and High-Throughput Synthesis
3.4.2. Restraints
3.4.2.1. High Cost and Technical Complexity of Long-Sequence DNA Synthesis
3.4.2.2. Ethical, Regulatory, and Biosecurity Concerns
3.4.3. Opportunities
3.4.3.1. Expansion of Gene and Cell Therapy Applications
CHAPTER 4: DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE
4.1. Overview
4.1.1. Market size and forecast
4.2. Product
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Product DNA Synthesis Market by Type
4.2.4.1. Instruments Market size and forecast, by region
4.2.4.2. Reagents and Consumables Market size and forecast, by region
4.3. Services
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: DNA SYNTHESIS MARKET, BY TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Oligonucleotide Synthesis
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Gene Synthesis
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: DNA SYNTHESIS MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Diagnostics
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Therapeutics
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Research and Development
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: DNA SYNTHESIS MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Pharmaceutical and Biotechnology Companies
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Diagnostic Companies
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Academic and Research Institutes
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
7.5. Others
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by region
7.5.3. Market share analysis by country
CHAPTER 8: DNA SYNTHESIS MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast, by Product and Service
8.2.2.1. North America Product DNA Synthesis Market by Type
8.2.3. Market size and forecast, by Type
8.2.4. Market size and forecast, by Application
8.2.5. Market size and forecast, by End User
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Market size and forecast, by Product and Service
8.2.6.1.2. Market size and forecast, by Type
8.2.6.1.3. Market size and forecast, by Application
8.2.6.1.4. Market size and forecast, by End User
8.2.6.2. Canada
8.2.6.2.1. Market size and forecast, by Product and Service
8.2.6.2.2. Market size and forecast, by Type
8.2.6.2.3. Market size and forecast, by Application
8.2.6.2.4. Market size and forecast, by End User
8.2.6.3. Mexico
8.2.6.3.1. Market size and forecast, by Product and Service
8.2.6.3.2. Market size and forecast, by Type
8.2.6.3.3. Market size and forecast, by Application
8.2.6.3.4. Market size and forecast, by End User
8.3. Europe
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast, by Product and Service
8.3.2.1. Europe Product DNA Synthesis Market by Type
8.3.3. Market size and forecast, by Type
8.3.4. Market size and forecast, by Application
8.3.5. Market size and forecast, by End User
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Market size and forecast, by Product and Service
8.3.6.1.2. Market size and forecast, by Type
8.3.6.1.3. Market size and forecast, by Application
8.3.6.1.4. Market size and forecast, by End User
8.3.6.2. France
8.3.6.2.1. Market size and forecast, by Product and Service
8.3.6.2.2. Market size and forecast, by Type
8.3.6.2.3. Market size and forecast, by Application
8.3.6.2.4. Market size and forecast, by End User
8.3.6.3. UK
8.3.6.3.1. Market size and forecast, by Product and Service
8.3.6.3.2. Market size and forecast, by Type
8.3.6.3.3. Market size and forecast, by Application
8.3.6.3.4. Market size and forecast, by End User
8.3.6.4. Italy
8.3.6.4.1. Market size and forecast, by Product and Service
8.3.6.4.2. Market size and forecast, by Type
8.3.6.4.3. Market size and forecast, by Application
8.3.6.4.4. Market size and forecast, by End User
8.3.6.5. Spain
8.3.6.5.1. Market size and forecast, by Product and Service
8.3.6.5.2. Market size and forecast, by Type
8.3.6.5.3. Market size and forecast, by Application
8.3.6.5.4. Market size and forecast, by End User
8.3.6.6. Rest of Europe
8.3.6.6.1. Market size and forecast, by Product and Service
8.3.6.6.2. Market size and forecast, by Type
8.3.6.6.3. Market size and forecast, by Application
8.3.6.6.4. Market size and forecast, by End User
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast, by Product and Service
8.4.2.1. Asia-Pacific Product DNA Synthesis Market by Type
8.4.3. Market size and forecast, by Type
8.4.4. Market size and forecast, by Application
8.4.5. Market size and forecast, by End User
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Market size and forecast, by Product and Service
8.4.6.1.2. Market size and forecast, by Type
8.4.6.1.3. Market size and forecast, by Application
8.4.6.1.4. Market size and forecast, by End User
8.4.6.2. China
8.4.6.2.1. Market size and forecast, by Product and Service
8.4.6.2.2. Market size and forecast, by Type
8.4.6.2.3. Market size and forecast, by Application
8.4.6.2.4. Market size and forecast, by End User
8.4.6.3. India
8.4.6.3.1. Market size and forecast, by Product and Service
8.4.6.3.2. Market size and forecast, by Type
8.4.6.3.3. Market size and forecast, by Application
8.4.6.3.4. Market size and forecast, by End User
8.4.6.4. Australia
8.4.6.4.1. Market size and forecast, by Product and Service
8.4.6.4.2. Market size and forecast, by Type
8.4.6.4.3. Market size and forecast, by Application
8.4.6.4.4. Market size and forecast, by End User
8.4.6.5. South Korea
8.4.6.5.1. Market size and forecast, by Product and Service
8.4.6.5.2. Market size and forecast, by Type
8.4.6.5.3. Market size and forecast, by Application
8.4.6.5.4. Market size and forecast, by End User
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Market size and forecast, by Product and Service
8.4.6.6.2. Market size and forecast, by Type
8.4.6.6.3. Market size and forecast, by Application
8.4.6.6.4. Market size and forecast, by End User
8.5. LAMEA
8.5.1. Key market trends, growth factors and opportunities
8.5.2. Market size and forecast, by Product and Service
8.5.2.1. LAMEA Product DNA Synthesis Market by Type
8.5.3. Market size and forecast, by Type
8.5.4. Market size and forecast, by Application
8.5.5. Market size and forecast, by End User
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Market size and forecast, by Product and Service
8.5.6.1.2. Market size and forecast, by Type
8.5.6.1.3. Market size and forecast, by Application
8.5.6.1.4. Market size and forecast, by End User
8.5.6.2. Saudi Arabia
8.5.6.2.1. Market size and forecast, by Product and Service
8.5.6.2.2. Market size and forecast, by Type
8.5.6.2.3. Market size and forecast, by Application
8.5.6.2.4. Market size and forecast, by End User
8.5.6.3. South Africa
8.5.6.3.1. Market size and forecast, by Product and Service
8.5.6.3.2. Market size and forecast, by Type
8.5.6.3.3. Market size and forecast, by Application
8.5.6.3.4. Market size and forecast, by End User
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Market size and forecast, by Product and Service
8.5.6.4.2. Market size and forecast, by Type
8.5.6.4.3. Market size and forecast, by Application
8.5.6.4.4. Market size and forecast, by End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product mapping of top 10 player
9.4. Competitive dashboard
9.5. Competitive heatmap
9.6. Top player positioning, 2025
CHAPTER 10: COMPANY PROFILES
10.1. Bioneer Corporation
10.1.1. Company overview
10.1.2. Key executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Business performance
10.2. Danaher Corporation
10.2.1. Company overview
10.2.2. Key executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.2.7. Key strategic moves and developments
10.3. Eurofins Scientific SE
10.3.1. Company overview
10.3.2. Key executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Business performance
10.4. Thermo Fisher Scientific Inc.
10.4.1. Company overview
10.4.2. Key executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Business performance
10.5. Twist Bioscience
10.5.1. Company overview
10.5.2. Key executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.5.6. Business performance
10.6. GenScript Biotech Corporation
10.6.1. Company overview
10.6.2. Key executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Business performance
10.7. Telesis Bio
10.7.1. Company overview
10.7.2. Key executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Business performance
10.8. Azenta Inc.
10.8.1. Company overview
10.8.2. Key executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.8.6. Business performance
10.9. Ajinomoto Bio-Pharma
10.9.1. Company overview
10.9.2. Key executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.9.6. Business performance
10.10. Merck KGaA
10.10.1. Company overview
10.10.2. Key executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
10.10.6. Business performance
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. High intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rising Demand for Genomics and Precision Medicine
3.4.1.2. Growth in Synthetic Biology and Biopharmaceutical Innovation
3.4.1.3. Technological Advancements in Automation and High-Throughput Synthesis
3.4.2. Restraints
3.4.2.1. High Cost and Technical Complexity of Long-Sequence DNA Synthesis
3.4.2.2. Ethical, Regulatory, and Biosecurity Concerns
3.4.3. Opportunities
3.4.3.1. Expansion of Gene and Cell Therapy Applications
CHAPTER 4: DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE
4.1. Overview
4.1.1. Market size and forecast
4.2. Product
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Product DNA Synthesis Market by Type
4.2.4.1. Instruments Market size and forecast, by region
4.2.4.2. Reagents and Consumables Market size and forecast, by region
4.3. Services
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: DNA SYNTHESIS MARKET, BY TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Oligonucleotide Synthesis
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Gene Synthesis
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: DNA SYNTHESIS MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Diagnostics
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Therapeutics
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Research and Development
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: DNA SYNTHESIS MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Pharmaceutical and Biotechnology Companies
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Diagnostic Companies
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Academic and Research Institutes
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
7.5. Others
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by region
7.5.3. Market share analysis by country
CHAPTER 8: DNA SYNTHESIS MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast, by Product and Service
8.2.2.1. North America Product DNA Synthesis Market by Type
8.2.3. Market size and forecast, by Type
8.2.4. Market size and forecast, by Application
8.2.5. Market size and forecast, by End User
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Market size and forecast, by Product and Service
8.2.6.1.2. Market size and forecast, by Type
8.2.6.1.3. Market size and forecast, by Application
8.2.6.1.4. Market size and forecast, by End User
8.2.6.2. Canada
8.2.6.2.1. Market size and forecast, by Product and Service
8.2.6.2.2. Market size and forecast, by Type
8.2.6.2.3. Market size and forecast, by Application
8.2.6.2.4. Market size and forecast, by End User
8.2.6.3. Mexico
8.2.6.3.1. Market size and forecast, by Product and Service
8.2.6.3.2. Market size and forecast, by Type
8.2.6.3.3. Market size and forecast, by Application
8.2.6.3.4. Market size and forecast, by End User
8.3. Europe
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast, by Product and Service
8.3.2.1. Europe Product DNA Synthesis Market by Type
8.3.3. Market size and forecast, by Type
8.3.4. Market size and forecast, by Application
8.3.5. Market size and forecast, by End User
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Market size and forecast, by Product and Service
8.3.6.1.2. Market size and forecast, by Type
8.3.6.1.3. Market size and forecast, by Application
8.3.6.1.4. Market size and forecast, by End User
8.3.6.2. France
8.3.6.2.1. Market size and forecast, by Product and Service
8.3.6.2.2. Market size and forecast, by Type
8.3.6.2.3. Market size and forecast, by Application
8.3.6.2.4. Market size and forecast, by End User
8.3.6.3. UK
8.3.6.3.1. Market size and forecast, by Product and Service
8.3.6.3.2. Market size and forecast, by Type
8.3.6.3.3. Market size and forecast, by Application
8.3.6.3.4. Market size and forecast, by End User
8.3.6.4. Italy
8.3.6.4.1. Market size and forecast, by Product and Service
8.3.6.4.2. Market size and forecast, by Type
8.3.6.4.3. Market size and forecast, by Application
8.3.6.4.4. Market size and forecast, by End User
8.3.6.5. Spain
8.3.6.5.1. Market size and forecast, by Product and Service
8.3.6.5.2. Market size and forecast, by Type
8.3.6.5.3. Market size and forecast, by Application
8.3.6.5.4. Market size and forecast, by End User
8.3.6.6. Rest of Europe
8.3.6.6.1. Market size and forecast, by Product and Service
8.3.6.6.2. Market size and forecast, by Type
8.3.6.6.3. Market size and forecast, by Application
8.3.6.6.4. Market size and forecast, by End User
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast, by Product and Service
8.4.2.1. Asia-Pacific Product DNA Synthesis Market by Type
8.4.3. Market size and forecast, by Type
8.4.4. Market size and forecast, by Application
8.4.5. Market size and forecast, by End User
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Market size and forecast, by Product and Service
8.4.6.1.2. Market size and forecast, by Type
8.4.6.1.3. Market size and forecast, by Application
8.4.6.1.4. Market size and forecast, by End User
8.4.6.2. China
8.4.6.2.1. Market size and forecast, by Product and Service
8.4.6.2.2. Market size and forecast, by Type
8.4.6.2.3. Market size and forecast, by Application
8.4.6.2.4. Market size and forecast, by End User
8.4.6.3. India
8.4.6.3.1. Market size and forecast, by Product and Service
8.4.6.3.2. Market size and forecast, by Type
8.4.6.3.3. Market size and forecast, by Application
8.4.6.3.4. Market size and forecast, by End User
8.4.6.4. Australia
8.4.6.4.1. Market size and forecast, by Product and Service
8.4.6.4.2. Market size and forecast, by Type
8.4.6.4.3. Market size and forecast, by Application
8.4.6.4.4. Market size and forecast, by End User
8.4.6.5. South Korea
8.4.6.5.1. Market size and forecast, by Product and Service
8.4.6.5.2. Market size and forecast, by Type
8.4.6.5.3. Market size and forecast, by Application
8.4.6.5.4. Market size and forecast, by End User
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Market size and forecast, by Product and Service
8.4.6.6.2. Market size and forecast, by Type
8.4.6.6.3. Market size and forecast, by Application
8.4.6.6.4. Market size and forecast, by End User
8.5. LAMEA
8.5.1. Key market trends, growth factors and opportunities
8.5.2. Market size and forecast, by Product and Service
8.5.2.1. LAMEA Product DNA Synthesis Market by Type
8.5.3. Market size and forecast, by Type
8.5.4. Market size and forecast, by Application
8.5.5. Market size and forecast, by End User
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Market size and forecast, by Product and Service
8.5.6.1.2. Market size and forecast, by Type
8.5.6.1.3. Market size and forecast, by Application
8.5.6.1.4. Market size and forecast, by End User
8.5.6.2. Saudi Arabia
8.5.6.2.1. Market size and forecast, by Product and Service
8.5.6.2.2. Market size and forecast, by Type
8.5.6.2.3. Market size and forecast, by Application
8.5.6.2.4. Market size and forecast, by End User
8.5.6.3. South Africa
8.5.6.3.1. Market size and forecast, by Product and Service
8.5.6.3.2. Market size and forecast, by Type
8.5.6.3.3. Market size and forecast, by Application
8.5.6.3.4. Market size and forecast, by End User
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Market size and forecast, by Product and Service
8.5.6.4.2. Market size and forecast, by Type
8.5.6.4.3. Market size and forecast, by Application
8.5.6.4.4. Market size and forecast, by End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product mapping of top 10 player
9.4. Competitive dashboard
9.5. Competitive heatmap
9.6. Top player positioning, 2025
CHAPTER 10: COMPANY PROFILES
10.1. Bioneer Corporation
10.1.1. Company overview
10.1.2. Key executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Business performance
10.2. Danaher Corporation
10.2.1. Company overview
10.2.2. Key executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.2.7. Key strategic moves and developments
10.3. Eurofins Scientific SE
10.3.1. Company overview
10.3.2. Key executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Business performance
10.4. Thermo Fisher Scientific Inc.
10.4.1. Company overview
10.4.2. Key executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Business performance
10.5. Twist Bioscience
10.5.1. Company overview
10.5.2. Key executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.5.6. Business performance
10.6. GenScript Biotech Corporation
10.6.1. Company overview
10.6.2. Key executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Business performance
10.7. Telesis Bio
10.7.1. Company overview
10.7.2. Key executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Business performance
10.8. Azenta Inc.
10.8.1. Company overview
10.8.2. Key executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.8.6. Business performance
10.9. Ajinomoto Bio-Pharma
10.9.1. Company overview
10.9.2. Key executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.9.6. Business performance
10.10. Merck KGaA
10.10.1. Company overview
10.10.2. Key executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
10.10.6. Business performance
LIST OF TABLES
TABLE 01. GLOBAL DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 02. DNA SYNTHESIS MARKET FOR PRODUCT, BY REGION, 2025-2035 ($MILLION)
TABLE 03. GLOBAL PRODUCT DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 04. DNA SYNTHESIS MARKET FOR INSTRUMENTS, BY REGION, 2025-2035 ($MILLION)
TABLE 05. DNA SYNTHESIS MARKET FOR REAGENTS AND CONSUMABLES, BY REGION, 2025-2035 ($MILLION)
TABLE 06. DNA SYNTHESIS MARKET FOR SERVICES, BY REGION, 2025-2035 ($MILLION)
TABLE 07. GLOBAL DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 08. DNA SYNTHESIS MARKET FOR OLIGONUCLEOTIDE SYNTHESIS, BY REGION, 2025-2035 ($MILLION)
TABLE 09. DNA SYNTHESIS MARKET FOR GENE SYNTHESIS, BY REGION, 2025-2035 ($MILLION)
TABLE 10. GLOBAL DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 11. DNA SYNTHESIS MARKET FOR DIAGNOSTICS, BY REGION, 2025-2035 ($MILLION)
TABLE 12. DNA SYNTHESIS MARKET FOR THERAPEUTICS, BY REGION, 2025-2035 ($MILLION)
TABLE 13. DNA SYNTHESIS MARKET FOR RESEARCH AND DEVELOPMENT, BY REGION, 2025-2035 ($MILLION)
TABLE 14. GLOBAL DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 15. DNA SYNTHESIS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2035 ($MILLION)
TABLE 16. DNA SYNTHESIS MARKET FOR DIAGNOSTIC COMPANIES, BY REGION, 2025-2035 ($MILLION)
TABLE 17. DNA SYNTHESIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2035 ($MILLION)
TABLE 18. DNA SYNTHESIS MARKET FOR OTHERS, BY REGION, 2025-2035 ($MILLION)
TABLE 19. DNA SYNTHESIS MARKET, BY REGION, 2025-2035 ($MILLION)
TABLE 20. NORTH AMERICA DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 21. NORTH AMERICA PRODUCT DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 22. NORTH AMERICA DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 23. NORTH AMERICA DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 24. NORTH AMERICA DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 25. NORTH AMERICA DNA SYNTHESIS MARKET, BY COUNTRY, 2025-2035 ($MILLION)
TABLE 26. U.S. DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 27. U.S. DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 28. U.S. DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 29. U.S. DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 30. CANADA DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 31. CANADA DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 32. CANADA DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 33. CANADA DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 34. MEXICO DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 35. MEXICO DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 36. MEXICO DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 37. MEXICO DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 38. EUROPE DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 39. EUROPE PRODUCT DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 40. EUROPE DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 41. EUROPE DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 42. EUROPE DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 43. EUROPE DNA SYNTHESIS MARKET, BY COUNTRY, 2025-2035 ($MILLION)
TABLE 44. GERMANY DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 45. GERMANY DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 46. GERMANY DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 47. GERMANY DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 48. FRANCE DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 49. FRANCE DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 50. FRANCE DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 51. FRANCE DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 52. UK DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 53. UK DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 54. UK DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 55. UK DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 56. ITALY DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 57. ITALY DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 58. ITALY DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 59. ITALY DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 60. SPAIN DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 61. SPAIN DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 62. SPAIN DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 63. SPAIN DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 64. REST OF EUROPE DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 65. REST OF EUROPE DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 66. REST OF EUROPE DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 67. REST OF EUROPE DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 68. ASIA-PACIFIC DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 69. ASIA-PACIFIC PRODUCT DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 70. ASIA-PACIFIC DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 71. ASIA-PACIFIC DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 72. ASIA-PACIFIC DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 73. ASIA-PACIFIC DNA SYNTHESIS MARKET, BY COUNTRY, 2025-2035 ($MILLION)
TABLE 74. JAPAN DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 75. JAPAN DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 76. JAPAN DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 77. JAPAN DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 78. CHINA DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 79. CHINA DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 80. CHINA DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 81. CHINA DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 82. INDIA DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 83. INDIA DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 84. INDIA DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 85. INDIA DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 86. AUSTRALIA DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 87. AUSTRALIA DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 88. AUSTRALIA DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 89. AUSTRALIA DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 90. SOUTH KOREA DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 91. SOUTH KOREA DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 92. SOUTH KOREA DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 93. SOUTH KOREA DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 94. REST OF ASIA-PACIFIC DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 95. REST OF ASIA-PACIFIC DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 96. REST OF ASIA-PACIFIC DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 97. REST OF ASIA-PACIFIC DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 98. LAMEA DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 99. LAMEA PRODUCT DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 100. LAMEA DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 101. LAMEA DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 102. LAMEA DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 103. LAMEA DNA SYNTHESIS MARKET, BY COUNTRY, 2025-2035 ($MILLION)
TABLE 104. BRAZIL DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 105. BRAZIL DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 106. BRAZIL DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 107. BRAZIL DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 108. SAUDI ARABIA DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 109. SAUDI ARABIA DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 110. SAUDI ARABIA DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 111. SAUDI ARABIA DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 112. SOUTH AFRICA DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 113. SOUTH AFRICA DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 114. SOUTH AFRICA DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 115. SOUTH AFRICA DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 116. REST OF LAMEA DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 117. REST OF LAMEA DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 118. REST OF LAMEA DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 119. REST OF LAMEA DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 120. BIONEER CORPORATION: KEY EXECUTIVES
TABLE 121. BIONEER CORPORATION: COMPANY SNAPSHOT
TABLE 122. BIONEER CORPORATION: PRODUCT SEGMENTS
TABLE 123. BIONEER CORPORATION: PRODUCT PORTFOLIO
TABLE 124. DANAHER CORPORATION: KEY EXECUTIVES
TABLE 125. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 126. DANAHER CORPORATION: PRODUCT SEGMENTS
TABLE 127. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 128. DANAHER CORPORATION: KEY STRATERGIES
TABLE 129. EUROFINS SCIENTIFIC SE: KEY EXECUTIVES
TABLE 130. EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT
TABLE 131. EUROFINS SCIENTIFIC SE: PRODUCT SEGMENTS
TABLE 132. EUROFINS SCIENTIFIC SE: PRODUCT PORTFOLIO
TABLE 133. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
TABLE 134. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
TABLE 135. THERMO FISHER SCIENTIFIC INC.: PRODUCT SEGMENTS
TABLE 136. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
TABLE 137. TWIST BIOSCIENCE: KEY EXECUTIVES
TABLE 138. TWIST BIOSCIENCE: COMPANY SNAPSHOT
TABLE 139. TWIST BIOSCIENCE: PRODUCT SEGMENTS
TABLE 140. TWIST BIOSCIENCE: PRODUCT PORTFOLIO
TABLE 141. GENSCRIPT BIOTECH CORPORATION: KEY EXECUTIVES
TABLE 142. GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT
TABLE 143. GENSCRIPT BIOTECH CORPORATION: PRODUCT SEGMENTS
TABLE 144. GENSCRIPT BIOTECH CORPORATION: PRODUCT PORTFOLIO
TABLE 145. TELESIS BIO: KEY EXECUTIVES
TABLE 146. TELESIS BIO: COMPANY SNAPSHOT
TABLE 147. TELESIS BIO: PRODUCT SEGMENTS
TABLE 148. TELESIS BIO: PRODUCT PORTFOLIO
TABLE 149. AZENTA INC.: KEY EXECUTIVES
TABLE 150. AZENTA INC.: COMPANY SNAPSHOT
TABLE 151. AZENTA INC.: PRODUCT SEGMENTS
TABLE 152. AZENTA INC.: PRODUCT PORTFOLIO
TABLE 153. AJINOMOTO BIO-PHARMA: KEY EXECUTIVES
TABLE 154. AJINOMOTO BIO-PHARMA: COMPANY SNAPSHOT
TABLE 155. AJINOMOTO BIO-PHARMA: PRODUCT SEGMENTS
TABLE 156. AJINOMOTO BIO-PHARMA: PRODUCT PORTFOLIO
TABLE 157. MERCK KGAA: KEY EXECUTIVES
TABLE 158. MERCK KGAA: COMPANY SNAPSHOT
TABLE 159. MERCK KGAA: PRODUCT SEGMENTS
TABLE 160. MERCK KGAA: PRODUCT PORTFOLIO
TABLE 01. GLOBAL DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 02. DNA SYNTHESIS MARKET FOR PRODUCT, BY REGION, 2025-2035 ($MILLION)
TABLE 03. GLOBAL PRODUCT DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 04. DNA SYNTHESIS MARKET FOR INSTRUMENTS, BY REGION, 2025-2035 ($MILLION)
TABLE 05. DNA SYNTHESIS MARKET FOR REAGENTS AND CONSUMABLES, BY REGION, 2025-2035 ($MILLION)
TABLE 06. DNA SYNTHESIS MARKET FOR SERVICES, BY REGION, 2025-2035 ($MILLION)
TABLE 07. GLOBAL DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 08. DNA SYNTHESIS MARKET FOR OLIGONUCLEOTIDE SYNTHESIS, BY REGION, 2025-2035 ($MILLION)
TABLE 09. DNA SYNTHESIS MARKET FOR GENE SYNTHESIS, BY REGION, 2025-2035 ($MILLION)
TABLE 10. GLOBAL DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 11. DNA SYNTHESIS MARKET FOR DIAGNOSTICS, BY REGION, 2025-2035 ($MILLION)
TABLE 12. DNA SYNTHESIS MARKET FOR THERAPEUTICS, BY REGION, 2025-2035 ($MILLION)
TABLE 13. DNA SYNTHESIS MARKET FOR RESEARCH AND DEVELOPMENT, BY REGION, 2025-2035 ($MILLION)
TABLE 14. GLOBAL DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 15. DNA SYNTHESIS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2035 ($MILLION)
TABLE 16. DNA SYNTHESIS MARKET FOR DIAGNOSTIC COMPANIES, BY REGION, 2025-2035 ($MILLION)
TABLE 17. DNA SYNTHESIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2035 ($MILLION)
TABLE 18. DNA SYNTHESIS MARKET FOR OTHERS, BY REGION, 2025-2035 ($MILLION)
TABLE 19. DNA SYNTHESIS MARKET, BY REGION, 2025-2035 ($MILLION)
TABLE 20. NORTH AMERICA DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 21. NORTH AMERICA PRODUCT DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 22. NORTH AMERICA DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 23. NORTH AMERICA DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 24. NORTH AMERICA DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 25. NORTH AMERICA DNA SYNTHESIS MARKET, BY COUNTRY, 2025-2035 ($MILLION)
TABLE 26. U.S. DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 27. U.S. DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 28. U.S. DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 29. U.S. DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 30. CANADA DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 31. CANADA DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 32. CANADA DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 33. CANADA DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 34. MEXICO DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 35. MEXICO DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 36. MEXICO DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 37. MEXICO DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 38. EUROPE DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 39. EUROPE PRODUCT DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 40. EUROPE DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 41. EUROPE DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 42. EUROPE DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 43. EUROPE DNA SYNTHESIS MARKET, BY COUNTRY, 2025-2035 ($MILLION)
TABLE 44. GERMANY DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 45. GERMANY DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 46. GERMANY DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 47. GERMANY DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 48. FRANCE DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 49. FRANCE DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 50. FRANCE DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 51. FRANCE DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 52. UK DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 53. UK DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 54. UK DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 55. UK DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 56. ITALY DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 57. ITALY DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 58. ITALY DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 59. ITALY DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 60. SPAIN DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 61. SPAIN DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 62. SPAIN DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 63. SPAIN DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 64. REST OF EUROPE DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 65. REST OF EUROPE DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 66. REST OF EUROPE DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 67. REST OF EUROPE DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 68. ASIA-PACIFIC DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 69. ASIA-PACIFIC PRODUCT DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 70. ASIA-PACIFIC DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 71. ASIA-PACIFIC DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 72. ASIA-PACIFIC DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 73. ASIA-PACIFIC DNA SYNTHESIS MARKET, BY COUNTRY, 2025-2035 ($MILLION)
TABLE 74. JAPAN DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 75. JAPAN DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 76. JAPAN DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 77. JAPAN DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 78. CHINA DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 79. CHINA DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 80. CHINA DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 81. CHINA DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 82. INDIA DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 83. INDIA DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 84. INDIA DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 85. INDIA DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 86. AUSTRALIA DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 87. AUSTRALIA DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 88. AUSTRALIA DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 89. AUSTRALIA DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 90. SOUTH KOREA DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 91. SOUTH KOREA DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 92. SOUTH KOREA DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 93. SOUTH KOREA DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 94. REST OF ASIA-PACIFIC DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 95. REST OF ASIA-PACIFIC DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 96. REST OF ASIA-PACIFIC DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 97. REST OF ASIA-PACIFIC DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 98. LAMEA DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 99. LAMEA PRODUCT DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 100. LAMEA DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 101. LAMEA DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 102. LAMEA DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 103. LAMEA DNA SYNTHESIS MARKET, BY COUNTRY, 2025-2035 ($MILLION)
TABLE 104. BRAZIL DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 105. BRAZIL DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 106. BRAZIL DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 107. BRAZIL DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 108. SAUDI ARABIA DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 109. SAUDI ARABIA DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 110. SAUDI ARABIA DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 111. SAUDI ARABIA DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 112. SOUTH AFRICA DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 113. SOUTH AFRICA DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 114. SOUTH AFRICA DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 115. SOUTH AFRICA DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 116. REST OF LAMEA DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025-2035 ($MILLION)
TABLE 117. REST OF LAMEA DNA SYNTHESIS MARKET, BY TYPE, 2025-2035 ($MILLION)
TABLE 118. REST OF LAMEA DNA SYNTHESIS MARKET, BY APPLICATION, 2025-2035 ($MILLION)
TABLE 119. REST OF LAMEA DNA SYNTHESIS MARKET, BY END USER, 2025-2035 ($MILLION)
TABLE 120. BIONEER CORPORATION: KEY EXECUTIVES
TABLE 121. BIONEER CORPORATION: COMPANY SNAPSHOT
TABLE 122. BIONEER CORPORATION: PRODUCT SEGMENTS
TABLE 123. BIONEER CORPORATION: PRODUCT PORTFOLIO
TABLE 124. DANAHER CORPORATION: KEY EXECUTIVES
TABLE 125. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 126. DANAHER CORPORATION: PRODUCT SEGMENTS
TABLE 127. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 128. DANAHER CORPORATION: KEY STRATERGIES
TABLE 129. EUROFINS SCIENTIFIC SE: KEY EXECUTIVES
TABLE 130. EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT
TABLE 131. EUROFINS SCIENTIFIC SE: PRODUCT SEGMENTS
TABLE 132. EUROFINS SCIENTIFIC SE: PRODUCT PORTFOLIO
TABLE 133. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
TABLE 134. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
TABLE 135. THERMO FISHER SCIENTIFIC INC.: PRODUCT SEGMENTS
TABLE 136. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
TABLE 137. TWIST BIOSCIENCE: KEY EXECUTIVES
TABLE 138. TWIST BIOSCIENCE: COMPANY SNAPSHOT
TABLE 139. TWIST BIOSCIENCE: PRODUCT SEGMENTS
TABLE 140. TWIST BIOSCIENCE: PRODUCT PORTFOLIO
TABLE 141. GENSCRIPT BIOTECH CORPORATION: KEY EXECUTIVES
TABLE 142. GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT
TABLE 143. GENSCRIPT BIOTECH CORPORATION: PRODUCT SEGMENTS
TABLE 144. GENSCRIPT BIOTECH CORPORATION: PRODUCT PORTFOLIO
TABLE 145. TELESIS BIO: KEY EXECUTIVES
TABLE 146. TELESIS BIO: COMPANY SNAPSHOT
TABLE 147. TELESIS BIO: PRODUCT SEGMENTS
TABLE 148. TELESIS BIO: PRODUCT PORTFOLIO
TABLE 149. AZENTA INC.: KEY EXECUTIVES
TABLE 150. AZENTA INC.: COMPANY SNAPSHOT
TABLE 151. AZENTA INC.: PRODUCT SEGMENTS
TABLE 152. AZENTA INC.: PRODUCT PORTFOLIO
TABLE 153. AJINOMOTO BIO-PHARMA: KEY EXECUTIVES
TABLE 154. AJINOMOTO BIO-PHARMA: COMPANY SNAPSHOT
TABLE 155. AJINOMOTO BIO-PHARMA: PRODUCT SEGMENTS
TABLE 156. AJINOMOTO BIO-PHARMA: PRODUCT PORTFOLIO
TABLE 157. MERCK KGAA: KEY EXECUTIVES
TABLE 158. MERCK KGAA: COMPANY SNAPSHOT
TABLE 159. MERCK KGAA: PRODUCT SEGMENTS
TABLE 160. MERCK KGAA: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. DNA SYNTHESIS MARKET, 2025-2035
FIGURE 02. SEGMENTATION OF DNA SYNTHESIS MARKET,2025-2035
FIGURE 03. TOP IMPACTING FACTORS IN DNA SYNTHESIS MARKET (2025 TO 2035)
FIGURE 04. TOP INVESTMENT POCKETS IN DNA SYNTHESIS MARKET (2026-2035)
FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. MODERATE THREAT OF SUBSTITUTES
FIGURE 08. HIGH INTENSITY OF RIVALRY
FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
FIGURE 10. GLOBAL DNA SYNTHESIS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025 AND 2035(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF DNA SYNTHESIS MARKET FOR PRODUCT, BY COUNTRY 2025 AND 2035(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF DNA SYNTHESIS MARKET FOR SERVICES, BY COUNTRY 2025 AND 2035(%)
FIGURE 14. DNA SYNTHESIS MARKET, BY TYPE, 2025 AND 2035(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF DNA SYNTHESIS MARKET FOR OLIGONUCLEOTIDE SYNTHESIS, BY COUNTRY 2025 AND 2035(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF DNA SYNTHESIS MARKET FOR GENE SYNTHESIS, BY COUNTRY 2025 AND 2035(%)
FIGURE 17. DNA SYNTHESIS MARKET, BY APPLICATION, 2025 AND 2035(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF DNA SYNTHESIS MARKET FOR DIAGNOSTICS, BY COUNTRY 2025 AND 2035(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF DNA SYNTHESIS MARKET FOR THERAPEUTICS, BY COUNTRY 2025 AND 2035(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF DNA SYNTHESIS MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY 2025 AND 2035(%)
FIGURE 21. DNA SYNTHESIS MARKET, BY END USER, 2025 AND 2035(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF DNA SYNTHESIS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY 2025 AND 2035(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF DNA SYNTHESIS MARKET FOR DIAGNOSTIC COMPANIES, BY COUNTRY 2025 AND 2035(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF DNA SYNTHESIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY 2025 AND 2035(%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF DNA SYNTHESIS MARKET FOR OTHERS, BY COUNTRY 2025 AND 2035(%)
FIGURE 26. DNA SYNTHESIS MARKET BY REGION, 2025 AND 2035(%)
FIGURE 27. U.S. DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 28. CANADA DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 29. MEXICO DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 30. GERMANY DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 31. FRANCE DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 32. UK DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 33. ITALY DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 34. SPAIN DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 35. REST OF EUROPE DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 36. JAPAN DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 37. CHINA DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 38. INDIA DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 39. AUSTRALIA DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 40. SOUTH KOREA DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 41. REST OF ASIA-PACIFIC DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 42. BRAZIL DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 43. SAUDI ARABIA DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 44. SOUTH AFRICA DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 45. REST OF LAMEA DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 46. TOP WINNING STRATEGIES, BY YEAR (2024)
FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT (2024)
FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY (2024)
FIGURE 49. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 50. COMPETITIVE DASHBOARD
FIGURE 51. COMPETITIVE HEATMAP: DNA SYNTHESIS MARKET
FIGURE 52. TOP PLAYER POSITIONING, 2025
FIGURE 53. BIONEER CORPORATION: NET REVENUE, 2022-2024 ($MILLION)
FIGURE 54. EUROFINS SCIENTIFIC SE: NET REVENUE, 2023-2025 ($MILLION)
FIGURE 55. EUROFINS SCIENTIFIC SE: REVENUE SHARE BY SEGMENT, 2025 (%)
FIGURE 56. EUROFINS SCIENTIFIC SE: REVENUE SHARE BY REGION, 2025 (%)
FIGURE 57. THERMO FISHER SCIENTIFIC INC.: NET REVENUE, 2023-2025 ($MILLION)
FIGURE 58. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY SEGMENT, 2025 (%)
FIGURE 59. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY REGION, 2025 (%)
FIGURE 60. TWIST BIOSCIENCE: NET REVENUE, 2023-2025 ($MILLION)
FIGURE 61. TWIST BIOSCIENCE: REVENUE SHARE BY REGION, 2025 (%)
FIGURE 62. TWIST BIOSCIENCE: REVENUE SHARE BY SEGMENT, 2025 (%)
FIGURE 63. GENSCRIPT BIOTECH CORPORATION: NET REVENUE, 2023-2025 ($MILLION)
FIGURE 64. GENSCRIPT BIOTECH CORPORATION: REVENUE SHARE BY SEGMENT, 2025 (%)
FIGURE 65. GENSCRIPT BIOTECH CORPORATION: REVENUE SHARE BY REGION, 2025 (%)
FIGURE 66. TELESIS BIO: NET REVENUE, 2021-2023 ($MILLION)
FIGURE 67. TELESIS BIO: REVENUE SHARE BY SEGMENT, 2023 (%)
FIGURE 68. AZENTA INC.: NET SALES, 2023-2025 ($MILLION)
FIGURE 69. AZENTA INC.: REVENUE SHARE BY SEGMENT, 2025 (%)
FIGURE 70. AZENTA INC.: REVENUE SHARE BY REGION, 2025 (%)
FIGURE 71. AJINOMOTO BIO-PHARMA: NET REVENUE, 2022-2024 ($MILLION)
FIGURE 72. AJINOMOTO BIO-PHARMA: REVENUE SHARE BY SEGMENT, 2024 (%)
FIGURE 73. MERCK KGAA: NET SALES, 2023-2025 ($MILLION)
FIGURE 74. MERCK KGAA: REVENUE SHARE BY SEGMENT, 2025 (%)
FIGURE 75. MERCK KGAA: REVENUE SHARE BY REGION, 2025 (%)
FIGURE 01. DNA SYNTHESIS MARKET, 2025-2035
FIGURE 02. SEGMENTATION OF DNA SYNTHESIS MARKET,2025-2035
FIGURE 03. TOP IMPACTING FACTORS IN DNA SYNTHESIS MARKET (2025 TO 2035)
FIGURE 04. TOP INVESTMENT POCKETS IN DNA SYNTHESIS MARKET (2026-2035)
FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. MODERATE THREAT OF SUBSTITUTES
FIGURE 08. HIGH INTENSITY OF RIVALRY
FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
FIGURE 10. GLOBAL DNA SYNTHESIS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE, 2025 AND 2035(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF DNA SYNTHESIS MARKET FOR PRODUCT, BY COUNTRY 2025 AND 2035(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF DNA SYNTHESIS MARKET FOR SERVICES, BY COUNTRY 2025 AND 2035(%)
FIGURE 14. DNA SYNTHESIS MARKET, BY TYPE, 2025 AND 2035(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF DNA SYNTHESIS MARKET FOR OLIGONUCLEOTIDE SYNTHESIS, BY COUNTRY 2025 AND 2035(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF DNA SYNTHESIS MARKET FOR GENE SYNTHESIS, BY COUNTRY 2025 AND 2035(%)
FIGURE 17. DNA SYNTHESIS MARKET, BY APPLICATION, 2025 AND 2035(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF DNA SYNTHESIS MARKET FOR DIAGNOSTICS, BY COUNTRY 2025 AND 2035(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF DNA SYNTHESIS MARKET FOR THERAPEUTICS, BY COUNTRY 2025 AND 2035(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF DNA SYNTHESIS MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY 2025 AND 2035(%)
FIGURE 21. DNA SYNTHESIS MARKET, BY END USER, 2025 AND 2035(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF DNA SYNTHESIS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY 2025 AND 2035(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF DNA SYNTHESIS MARKET FOR DIAGNOSTIC COMPANIES, BY COUNTRY 2025 AND 2035(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF DNA SYNTHESIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY 2025 AND 2035(%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF DNA SYNTHESIS MARKET FOR OTHERS, BY COUNTRY 2025 AND 2035(%)
FIGURE 26. DNA SYNTHESIS MARKET BY REGION, 2025 AND 2035(%)
FIGURE 27. U.S. DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 28. CANADA DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 29. MEXICO DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 30. GERMANY DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 31. FRANCE DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 32. UK DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 33. ITALY DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 34. SPAIN DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 35. REST OF EUROPE DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 36. JAPAN DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 37. CHINA DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 38. INDIA DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 39. AUSTRALIA DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 40. SOUTH KOREA DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 41. REST OF ASIA-PACIFIC DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 42. BRAZIL DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 43. SAUDI ARABIA DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 44. SOUTH AFRICA DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 45. REST OF LAMEA DNA SYNTHESIS MARKET, 2025-2035 ($MILLION)
FIGURE 46. TOP WINNING STRATEGIES, BY YEAR (2024)
FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT (2024)
FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY (2024)
FIGURE 49. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 50. COMPETITIVE DASHBOARD
FIGURE 51. COMPETITIVE HEATMAP: DNA SYNTHESIS MARKET
FIGURE 52. TOP PLAYER POSITIONING, 2025
FIGURE 53. BIONEER CORPORATION: NET REVENUE, 2022-2024 ($MILLION)
FIGURE 54. EUROFINS SCIENTIFIC SE: NET REVENUE, 2023-2025 ($MILLION)
FIGURE 55. EUROFINS SCIENTIFIC SE: REVENUE SHARE BY SEGMENT, 2025 (%)
FIGURE 56. EUROFINS SCIENTIFIC SE: REVENUE SHARE BY REGION, 2025 (%)
FIGURE 57. THERMO FISHER SCIENTIFIC INC.: NET REVENUE, 2023-2025 ($MILLION)
FIGURE 58. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY SEGMENT, 2025 (%)
FIGURE 59. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY REGION, 2025 (%)
FIGURE 60. TWIST BIOSCIENCE: NET REVENUE, 2023-2025 ($MILLION)
FIGURE 61. TWIST BIOSCIENCE: REVENUE SHARE BY REGION, 2025 (%)
FIGURE 62. TWIST BIOSCIENCE: REVENUE SHARE BY SEGMENT, 2025 (%)
FIGURE 63. GENSCRIPT BIOTECH CORPORATION: NET REVENUE, 2023-2025 ($MILLION)
FIGURE 64. GENSCRIPT BIOTECH CORPORATION: REVENUE SHARE BY SEGMENT, 2025 (%)
FIGURE 65. GENSCRIPT BIOTECH CORPORATION: REVENUE SHARE BY REGION, 2025 (%)
FIGURE 66. TELESIS BIO: NET REVENUE, 2021-2023 ($MILLION)
FIGURE 67. TELESIS BIO: REVENUE SHARE BY SEGMENT, 2023 (%)
FIGURE 68. AZENTA INC.: NET SALES, 2023-2025 ($MILLION)
FIGURE 69. AZENTA INC.: REVENUE SHARE BY SEGMENT, 2025 (%)
FIGURE 70. AZENTA INC.: REVENUE SHARE BY REGION, 2025 (%)
FIGURE 71. AJINOMOTO BIO-PHARMA: NET REVENUE, 2022-2024 ($MILLION)
FIGURE 72. AJINOMOTO BIO-PHARMA: REVENUE SHARE BY SEGMENT, 2024 (%)
FIGURE 73. MERCK KGAA: NET SALES, 2023-2025 ($MILLION)
FIGURE 74. MERCK KGAA: REVENUE SHARE BY SEGMENT, 2025 (%)
FIGURE 75. MERCK KGAA: REVENUE SHARE BY REGION, 2025 (%)
